Institutional investors purchased a net $2.1 million shares of ZIOP during the quarter ended December 2014 and now own 24.85% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MSDC MANAGEMENT LP Bought 1.4 Million shares of ZIOPHARM Oncology Inc
BELMONT GLOBAL ADVISORS, INC. Bought 653.0 Thousand shares of ZIOPHARM Oncology Inc
BLACKROCK FUND ADVISORS Bought 540.1 Thousand shares of ZIOPHARM Oncology Inc